149 related articles for article (PubMed ID: 1357081)
1. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
[TBL] [Abstract][Full Text] [Related]
2. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
[TBL] [Abstract][Full Text] [Related]
3. Simian immunodeficiency virus-specific cytotoxic T lymphocytes in rhesus monkeys: characterization and vaccine induction.
Letvin NL; Miller MD; Shen L; Chen ZW; Yasutomi Y
Semin Immunol; 1993 Jun; 5(3):215-23. PubMed ID: 8394161
[TBL] [Abstract][Full Text] [Related]
4. Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.
Voss G; Stahl-Hennig C; Petry H; Coulibaly C; Nick S; Fuchs D; Wachter H; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1397-400. PubMed ID: 1466966
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
[TBL] [Abstract][Full Text] [Related]
6. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.
Miller MD; Lord CI; Stallard V; Mazzara GP; Letvin NL
J Immunol; 1990 Jan; 144(1):122-8. PubMed ID: 2153161
[TBL] [Abstract][Full Text] [Related]
7. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
[TBL] [Abstract][Full Text] [Related]
10. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
11. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.
Yasutomi Y; Reimann KA; Lord CI; Miller MD; Letvin NL
J Virol; 1993 Mar; 67(3):1707-11. PubMed ID: 8437240
[TBL] [Abstract][Full Text] [Related]
12. Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection.
Polyanskaya N; Sharpe S; Cook N; Leech S; Banks J; Dennis M; Hall G; Stott J; Cranage M
AIDS Res Hum Retroviruses; 1997 Jul; 13(11):923-31. PubMed ID: 9223408
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.
Reimann KA; Tenner-Racz K; Racz P; Montefiori DC; Yasutomi Y; Lin W; Ransil BJ; Letvin NL
J Virol; 1994 Apr; 68(4):2362-70. PubMed ID: 8139022
[TBL] [Abstract][Full Text] [Related]
14. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV).
Dittmer U; Spring M; Petry H; Nisslein T; Rieckmann P; Lüke W; Stahl-Hennig C; Hunsmann G; Bodemer W
J Biotechnol; 1996 Jan; 44(1-3):105-10. PubMed ID: 8717393
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells and monocytes elicited by immunization of rhesus monkeys with antigen-pulsed dendritic cells control SIV replication.
Wagner GS; Miller CJ; McChesney MB
AIDS Res Hum Retroviruses; 2002 Jan; 18(2):143-8. PubMed ID: 11839147
[TBL] [Abstract][Full Text] [Related]
17. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
18. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune response of SIV-infected rhesus macaques.
McGraw TP; Vowels BR; Gershwin ME; Gardner MB
J Med Primatol; 1990; 19(3-4):177-87. PubMed ID: 1977918
[TBL] [Abstract][Full Text] [Related]
20. Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H.
Chan WL; Rodgers A; Grief C; Almond N; Ellis S; Flanagan B; Silvera P; Bootman J; Stott J; Kent K
AIDS; 1995 Mar; 9(3):223-8. PubMed ID: 7755909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
